Table 2.
Effect of AEATP on pancreatic insulin content (ng/mg pancreas) in type-2 diabetic Wistar rats.
| Pancreatic insulin content (ng/mg pancreas) | Control | Diabetic control | Glimepiride treated | 250 mg/kg of AEATP | 500 mg/kg of AEATP | 1000 mg/kg of AEATP |
|---|---|---|---|---|---|---|
| Basal | 106.6 ± 3.35 | 101.9 ± 2.62 | 102.3 ± 3.66 | 101.9 ± 5.75 | 97.8 ± 5.99 | 100.9 ± 5.81 |
| 28th day | 103.9 ± 5.24 | 56.0 ± 2.81a# | 99.9 ± 2.22b# | 67.0 ± 2.98b‡ | 77.33 ± 5.68b#, c# | 92.46 ± 3.14b#, c#, d† |
Each group (n = 6) represents mean ± standard error of means. Data was analyzed by using one-way ANOVA followed by Tukey's multiple test; a control, b diabetic control, c 250 mg/kg of AEATP, d 500 mg/kg of AEATP. *P < 0.0001, # P < 0.001, † P < 0.01, ‡ P < 0.05.